Clinical Trial Update: Enhanced Lung Protective Ventilation for ARDS Patients With PrismaLung [NA]

View source ↗

Summary

A clinical trial evaluating enhanced lung-protective ventilation for acute respiratory distress syndrome using PrismaLung has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• PrismaLung+

Snippet

Sponsor: Hôpital Européen Marseille | Conditions: Acute Respiratory Distress Syndrome | NA | Status: TERMINATED